March 12, 2024

Pliant Therapeutics

Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis

March 11, 2024

MOMA Therapeutics

MOMA Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer

March 11, 2024

Synnovation Therapeutics

Synnovation Therapeutics Announces First Patient Dosed in Phase I Trial with SNV1521, a PARP1 Selective Inhibitor for the Treatment of Solid Tumors

March 05, 2024

Flare Therapeutics

Flare Therapeutics to Present Immune Profiling Data From Urothelial Cancer Patients Treated with Anti-PD1 Therapy at AACR 2024 Annual Meeting

March 05, 2024

Tango Therapeutics

Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association For Cancer Research (AACR) Annual Meeting 2024

Load More

Sign up for weekly portfolio news.